Published in Nat Commun on December 17, 2014
LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res (2015) 0.78
Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms. World J Gastrointest Oncol (2016) 0.77
Decellularized scaffolds in regenerative medicine. Oncotarget (2016) 0.75
Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma. PLoS One (2016) 0.75
Twenty years of menin: emerging opportunities for restoration of transcription in MEN1. Endocr Relat Cancer (2017) 0.75
A MEN1 pancreatic neuroendocrine tumour mouse model, under temporal control. Endocr Connect (2017) 0.75
Epigenetic regulation by the menin pathway. Endocr Relat Cancer (2017) 0.75
Wnt/β-catenin signaling and disease. Cell (2012) 16.05
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
Convergence of Wnt, beta-catenin, and cadherin pathways. Science (2004) 13.13
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.93
Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.55
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development (2000) 5.30
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell (2004) 4.98
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (1988) 3.96
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev (2002) 3.80
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell (2005) 3.70
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol (2008) 2.97
mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes (2008) 2.64
Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A (2007) 2.61
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet (2013) 2.59
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A (2013) 2.49
Stabilization of beta-catenin impacts pancreas growth. Development (2006) 2.44
Population-based study of islet cell carcinoma. Ann Surg Oncol (2007) 2.44
Beta-catenin is essential for pancreatic acinar but not islet development. Development (2005) 2.38
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell (2010) 2.29
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res (2005) 1.92
Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr Biol (2005) 1.87
Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proc Natl Acad Sci U S A (2007) 1.77
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A (2013) 1.67
The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature (2012) 1.62
Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat Commun (2013) 1.57
The in vitro perfused pancreas. Methods Enzymol (1975) 1.56
Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res (2003) 1.54
Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia (2010) 1.35
β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One (2011) 1.25
Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem Sci (2013) 1.21
Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Int J Cancer (2010) 1.19
Expression of Wnt, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr (2003) 1.05
The T cell factor/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells. J Clin Endocrinol Metab (2008) 1.02
Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin. Mol Cell Biol (2009) 1.01
Current understanding of the molecular biology of pancreatic neuroendocrine tumors. J Natl Cancer Inst (2013) 0.96
Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene. Proc Natl Acad Sci U S A (2010) 0.96
Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice. Diabetologia (2009) 0.94
Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. Endocr Relat Cancer (2006) 0.91
Regulation of cyclin B2 expression and cell cycle G2/m transition by menin. J Biol Chem (2010) 0.90
18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals. Nucl Med Commun (2013) 0.89
{beta}-Catenin regulates airway smooth muscle contraction. Am J Physiol Lung Cell Mol Physiol (2010) 0.84
Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation. J Hepatol (2013) 0.82
MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1. Endocr Relat Cancer (2007) 0.81